Ikonisys SA announced the execution of a distribution collaboration for the sale of the Ikoniscope20 Digital Fluorescence Microscope Solution in the Middle East markets. As announced previously, the commercialization strategy of Ikonisys will focus on a direct /non-direct business model, being direct with its own sales force in major European countries and the United States, and working with qualified distributors that have a strong market presence in the fields of Anatomic and Molecular Pathology in their respective markets. As such, the new partnership with the Integrated Gulf Biosystems Group will focus on all major Middle East markets, including Saudi Arabia, the United Arab Emirates, Kuwait, Bahrain and also expand into some South Asian markets and India.

The partnership will focus on the entire Ikoniscope20 instruments family, comprising the medium-volume Ikoniscope20 instrument, as well as the newly developed Ikoniscope20max instrument, which allows high-volume laboratories to fully automate their oncology FISH testing. Both companies, IGB and Ikonisys, will co-exhibit and showcase Ikonisys' Technology at MedLab Middle East in Dubai, 6. to 9. February 2023.